Recent work has suggested that the pre-existing health of CD8+ T cells in patients with multiple myeloma determines TCE response, with a high abundance of exhausted-like CD8+ T cells predicting TCE resistance (22). The gene discussed is CD8A; the disease is AL amyloidosis.